cs representing 70% of sales. Crane has increased its dividend per share at an annualized rate of 12.6% over the past ten years. • We are removing Roche Holding (RHHBY). Dividend per share growth over the next few years appears increasingly likely to fall below our list's minimum 4% threshold. Scott L. Stac

are attending. One, Foundation Medicine, which uses genetic data to create diagnostic oncology tools, is generating huge buzz this year. In January, Roche Holding announced plans to take a majority stake in the company, in a transaction valued at $1 billion. The stock more than doubled the next day. Google Ve